REDUCING REGULATORY RISK

3R PHARMA CONSULTING provides cost-effective and timely solutions to strategic issues in regulatory filings in European, US, and other regions of the world.

We support our customers in achieving their goals in all phases of pharmaceutical development (pre-approval) as well as maintenance of marketed products (post-approval). Our particular long-term experience and competence in Regulatory Sciences and in Chemistry, Manufacturing and Control (CMC) / Quality as well as Clinical Development can be deployed to effectively reduce the risk of failure or delay.

Professional risk assessment contributes significantly to reducing the time from identification of a lead compound to submission and regulatory approval of a pharmaceutical product of high quality and well defined performance.